Font Size: a A A
Keyword [HER-2 positive breast cancer]
Result: 1 - 20 | Page: 1 of 2
1. Cai A Mixture Of Addition And Subtraction Treatment Of Her-2 Positive Breast Cancer, The Efficacy Of Clinical Research
2. Black Rice Anthocyanins Inhibit HER-2-Positive Breast Cancer Epithelial–Mesenchymal Transition And Cell Metastasis Via FAK Signaling In Vitro
3. Evaluation On Efficacy Of Trastuzumab In Her-2 Positive Breast Cancer Patients And Its Analysis Of Prognosis Influencing Factors
4. Prognostic Analysis Of Targeted Therapy On T1 Stage HER-2 Positive Breast Cancer
5. Study Of Expression Of BRCA1,FANCF,CD44+CD24- In Triple Negative And Luminal B (Her-2 Positive) Breast Cancer
6. The Role And Molecular Mechanism Of Autophahgy In Delphinidin-induced Anticancer Effects For HER-2 Positive Breast Cancer
7. Experimental Study Of Brain-Targeted Compound Nano Micelles In The Treatment Of Brain Metastases From HER-2-positive Breast Cancer
8. Analysis Of The Clinical And Pathological Features Of The HER-2 Positive Breast Cancer
9. The Predictive Value Of Tils For Trastuzumab In Her-2 Positive Breast Cancer
10. Comparison Of Efficacy Of THL And TCH Regimen In Neoadjuvant Treatment Of Her-2 Positive Breast Cancer
11. RBM38 Induces Tarstuzumab Sensitivity In HER-2 Positive Breast Cancer By Increasing The Expression Of HER-2
12. Advance In Molecular Targeted Therapy For HER-2 Positive Breast Cancer
13. Cardiotoxic Analysis Of Trastuzumab Treatment In Her-2 Positive Breast Cancer Patients
14. Molecular Mechanism Of Delphinidin Inducing Cell Cycle Arrest And Apoptosis In HER-2 Positive Breast Cancer Cells
15. The Cardiotoxicity Risks Of Anthracycline And Trastuzumab In HER-2 Positive Breast Cancer Patients
16. Application Of Magnetic Resonance Nanoparticles In HER-2 Positive Breast Cancer
17. The Clinical Observation Of Trastuzumab In The Real World For The Treatment Of Her-2 Positive Breast Cancer
18. Variation And Analysis Of Gene Copy Number In Her-2 Positive Breast Cancer
19. Expression Of P95HER2 And Its Clinical Value In HER-2 Positive Breast Cancer Patients
20. Clinical Study Of Neoadjuvant Chemotherapy With Trastuzumab For Breast Cancer With POSITIVE HER-2
  <<First  <Prev  Next>  Last>>  Jump to